6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
Research Grant
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
National Cancer Institute
Start Date
September 13, 2021
End Date
August 31, 2026
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
National Cancer Institute
Start Date
September 13, 2021
End Date
August 31, 2026